LONG-TERM SAFETY ASSESSMENT OF NIRAPARIB IN PATIENTS WITH RECURRENT OVARIAN CANCER: RESULTS FROM THE ENGOT-OV16/NOVA TRIAL

M. R. Mirza; A. Dorum; B. Benigno; S. Mahner; P. Bessette; I. M. Bover Barcelo; D. Berton; J. Ledermann; B. J. Rimel; J. Herrstedt; S. Lau; U. Canzler; I. Palacio Vazquez; E. Kalbacher; J. Buscema; D. Lorusso; P. Debruyne; I. Bruchim; W. Guo; D. Gupta; F. A. de Jong; U. A. Matulonis

doi:10.1136/ijgc-2019-ESGO.18

LONG-TERM SAFETY ASSESSMENT OF NIRAPARIB IN PATIENTS WITH RECURRENT OVARIAN CANCER: RESULTS FROM THE ENGOT-OV16/NOVA TRIAL

M. R. Mirza, A. Dorum, B. Benigno, S. Mahner, P. Bessette, I. M. Bover Barcelo, D. Berton, J. Ledermann, B. J. Rimel, J. Herrstedt, S. Lau, U. Canzler, I. Palacio Vazquez, E. Kalbacher, J. Buscema, D. Lorusso, P. Debruyne, I. Bruchim, W. Guo, D. GuptaF. A. de Jong, U. A. Matulonis

Medicine

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	A15-A16
Journal	International Journal of Gynecological Cancer
Volume	29
DOIs	https://doi.org/10.1136/ijgc-2019-ESGO.18
State	Published - Nov 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/ijgc-2019-ESGO.18

Cite this

Mirza, M. R., Dorum, A., Benigno, B., Mahner, S., Bessette, P., Bover Barcelo, I. M., Berton, D., Ledermann, J., Rimel, B. J., Herrstedt, J., Lau, S., Canzler, U., Palacio Vazquez, I., Kalbacher, E., Buscema, J., Lorusso, D., Debruyne, P., Bruchim, I., Guo, W., ... Matulonis, U. A. (2019). LONG-TERM SAFETY ASSESSMENT OF NIRAPARIB IN PATIENTS WITH RECURRENT OVARIAN CANCER: RESULTS FROM THE ENGOT-OV16/NOVA TRIAL. International Journal of Gynecological Cancer, 29, A15-A16. https://doi.org/10.1136/ijgc-2019-ESGO.18

@article{0e95979337c241e0b04987e88e8e72aa,

title = "LONG-TERM SAFETY ASSESSMENT OF NIRAPARIB IN PATIENTS WITH RECURRENT OVARIAN CANCER: RESULTS FROM THE ENGOT-OV16/NOVA TRIAL",

author = "Mirza, {M. R.} and A. Dorum and B. Benigno and S. Mahner and P. Bessette and {Bover Barcelo}, {I. M.} and D. Berton and J. Ledermann and Rimel, {B. J.} and J. Herrstedt and S. Lau and U. Canzler and {Palacio Vazquez}, I. and E. Kalbacher and J. Buscema and D. Lorusso and P. Debruyne and I. Bruchim and W. Guo and D. Gupta and {de Jong}, {F. A.} and Matulonis, {U. A.}",

year = "2019",

month = nov,

doi = "10.1136/ijgc-2019-ESGO.18",

language = "אנגלית",

volume = "29",

pages = "A15--A16",

}

Mirza, MR, Dorum, A, Benigno, B, Mahner, S, Bessette, P, Bover Barcelo, IM, Berton, D, Ledermann, J, Rimel, BJ, Herrstedt, J, Lau, S, Canzler, U, Palacio Vazquez, I, Kalbacher, E, Buscema, J, Lorusso, D, Debruyne, P, Bruchim, I, Guo, W, Gupta, D, de Jong, FA & Matulonis, UA 2019, 'LONG-TERM SAFETY ASSESSMENT OF NIRAPARIB IN PATIENTS WITH RECURRENT OVARIAN CANCER: RESULTS FROM THE ENGOT-OV16/NOVA TRIAL', International Journal of Gynecological Cancer, vol. 29, pp. A15-A16. https://doi.org/10.1136/ijgc-2019-ESGO.18

TY - JOUR

T1 - LONG-TERM SAFETY ASSESSMENT OF NIRAPARIB IN PATIENTS WITH RECURRENT OVARIAN CANCER: RESULTS FROM THE ENGOT-OV16/NOVA TRIAL

AU - Mirza, M. R.

AU - Dorum, A.

AU - Benigno, B.

AU - Mahner, S.

AU - Bessette, P.

AU - Bover Barcelo, I. M.

AU - Berton, D.

AU - Ledermann, J.

AU - Rimel, B. J.

AU - Herrstedt, J.

AU - Lau, S.

AU - Canzler, U.

AU - Palacio Vazquez, I.

AU - Kalbacher, E.

AU - Buscema, J.

AU - Lorusso, D.

AU - Debruyne, P.

AU - Bruchim, I.

AU - Guo, W.

AU - Gupta, D.

AU - de Jong, F. A.

AU - Matulonis, U. A.

PY - 2019/11

Y1 - 2019/11

U2 - 10.1136/ijgc-2019-ESGO.18

DO - 10.1136/ijgc-2019-ESGO.18

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.abstract???

SN - 1048-891X

VL - 29

SP - A15-A16

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

ER -